Tags

Type your tag names separated by a space and hit enter

Conscious sedation by oral administration of midazolam in paediatric dental treatment.
Swed Dent J. 2001; 25(3):97-104.SD

Abstract

Midazolam is a short-acting benzodiazepine with rapid onset, short duration of action and minimal side effects. The aim of this study was to evaluate the oral administration of midazolam as pre-operative sedation in the dental treatment of uncooperative pediatric patients. Included in the study were 160 children with a mean age of 6.7 +/- 2.6 years (1-14 years), 83 boys and 77 girls. All the patients had been referred for specialist treatment due to behavioral management problems. Treatment was performed in 250 sessions. All the children received an oral dose of 0.2 mg/kg body weight of midazolam. Acceptance of treatment was evaluated according to Rud & Kisling. Local anesthesia followed by restorative treatment and/or extractions constituted more than 90% of the performed treatments. Of the 250 sessions, 63% were performed with total acceptance and 30% with doubtful acceptance. In 7%, no treatment could be performed. No serious complications were registered during or after treatment. All the children were able to leave the clinic one hour after treatment. In conclusion, we consider oral administration of midazolam a safe form of premedication. The route of administration, the short waiting-time and half-life, in combination with a level of sedation that allows treatment to be performed, are the principal advantages of conscious sedation with orally administered midazolam.

Authors+Show Affiliations

Department of Odontology/Pedodontics, Umeä University, Sweden. anna-lena.erlandsson@nll.seNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11813451

Citation

Erlandsson, A L., et al. "Conscious Sedation By Oral Administration of Midazolam in Paediatric Dental Treatment." Swedish Dental Journal, vol. 25, no. 3, 2001, pp. 97-104.
Erlandsson AL, Bäckman B, Stenström A, et al. Conscious sedation by oral administration of midazolam in paediatric dental treatment. Swed Dent J. 2001;25(3):97-104.
Erlandsson, A. L., Bäckman, B., Stenström, A., & Stecksén-Blicks, C. (2001). Conscious sedation by oral administration of midazolam in paediatric dental treatment. Swedish Dental Journal, 25(3), 97-104.
Erlandsson AL, et al. Conscious Sedation By Oral Administration of Midazolam in Paediatric Dental Treatment. Swed Dent J. 2001;25(3):97-104. PubMed PMID: 11813451.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Conscious sedation by oral administration of midazolam in paediatric dental treatment. AU - Erlandsson,A L, AU - Bäckman,B, AU - Stenström,A, AU - Stecksén-Blicks,C, PY - 2002/1/30/pubmed PY - 2002/2/22/medline PY - 2002/1/30/entrez SP - 97 EP - 104 JF - Swedish dental journal JO - Swed Dent J VL - 25 IS - 3 N2 - Midazolam is a short-acting benzodiazepine with rapid onset, short duration of action and minimal side effects. The aim of this study was to evaluate the oral administration of midazolam as pre-operative sedation in the dental treatment of uncooperative pediatric patients. Included in the study were 160 children with a mean age of 6.7 +/- 2.6 years (1-14 years), 83 boys and 77 girls. All the patients had been referred for specialist treatment due to behavioral management problems. Treatment was performed in 250 sessions. All the children received an oral dose of 0.2 mg/kg body weight of midazolam. Acceptance of treatment was evaluated according to Rud & Kisling. Local anesthesia followed by restorative treatment and/or extractions constituted more than 90% of the performed treatments. Of the 250 sessions, 63% were performed with total acceptance and 30% with doubtful acceptance. In 7%, no treatment could be performed. No serious complications were registered during or after treatment. All the children were able to leave the clinic one hour after treatment. In conclusion, we consider oral administration of midazolam a safe form of premedication. The route of administration, the short waiting-time and half-life, in combination with a level of sedation that allows treatment to be performed, are the principal advantages of conscious sedation with orally administered midazolam. SN - 0347-9994 UR - https://www.unboundmedicine.com/medline/citation/11813451/Conscious_sedation_by_oral_administration_of_midazolam_in_paediatric_dental_treatment_ DB - PRIME DP - Unbound Medicine ER -